Toluene

Toluene

SCHEMBL4528819

Cc1ccccc1.N=S(=O)=O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 5/20 0.65
TSHR P16473 2/20 0.65
LMNA P02545 1/20 0.65
ALOX12 P18054 1/20 0.65
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
HPGD P15428 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
BCHE P06276 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
ALDH1A1 P00352 2/20 0.36
EPHX2 P34913 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CA12 O43570 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Toluene SCHEMBL2638449 0.88 ACHE (0.73) ACHETSHRLMNAALOX12CES2
Toluene SCHEMBL9091267 0.84
Toluene SCHEMBL1826322 0.82 ACHE (0.65) ACHETSHRLMNAALOX12CES2
Toluene SCHEMBL27705815 0.81 ACHE (0.73) ACHETSHRLMNAALOX12CES2
Toluene SCHEMBL28296994 0.81
Toluene SCHEMBL7662176 0.81
Toluene SCHEMBL4561853 0.81
Toluene SCHEMBL175861 0.80 ACHE (1.00) ACHETSHRLMNAALOX12CES2
Toluene SCHEMBL4429042 0.80 ACHE (1.00) ACHETSHRLMNAALOX12CES2
Toluene SCHEMBL8824270 0.80 ACHE (1.00) ACHETSHRLMNAALOX12CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107245444-A A kind of thorugh biologic engineering method cultivates the equipment and its breeding method of medical strain 徐州工程学院 2017-10-13 CN claimed
CN-105829305-B NRF2 regulator 葛兰素史密斯克莱知识产权发展有限公司 2018-11-30 CN disclosed
CN-107245444-A A kind of thorugh biologic engineering method cultivates the equipment and its breeding method of medical strain 徐州工程学院 2017-10-13 CN disclosed
CN-105829305-A NRF2 REGULATORS 葛兰素史密斯克莱知识产权发展有限公司 2016-08-03 CN disclosed
US-20090318548-A1 PARA-QUINOL DERIVATIVES AND METHODS OF STEREO SELECTIVELY SYNTHESIZING AND USING SAME UNIVERSITY OF NORTHERN BRITISH COLUMBIA (CA) 2009-12-24 US disclosed
WO-2008022462-A1 PARA-QUINOL DERIVATIVES AND METHODS OF STEREO SELECTIVELY SYNTHESIZING AND USING SAME UNIVERSITY OF NORTHERN BRITISH COLUMBIA (CA) 2008-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318548-A1 PARA-QUINOL DERIVATIVES AND METHODS OF STEREO SELECTIVELY SYNTHESIZING AND USING SAME CBR3, XDH, NQO2 ACHE 484/4885TSHR 4175/4885LMNA 1265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.